Compare Injective (INJ) vs SUPRA (SUPRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs SUPRA — how do they compare? Injective trades at Rp78,615 (market cap Rp7,84T, Rp671,51M 24h volume), while SUPRA trades at Rp3.07 (market cap Rp99,91M, Rp5,84M 24h volume). The key difference: Injective is far larger — about 78470.6× SUPRA's market cap, and SUPRA's supply is capped (32,7B / 100B SUPRA (33%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and SUPRA for 17 Days on average.
| INJ | SUPRA | |
|---|---|---|
Market Cap | Rp7,84T | Rp99,91M |
Volume (24h) | Rp671,51M | Rp5,84M |
Circulating Supply | 100M INJ | 32,7B / 100B SUPRA (33%) |
Typical Hold Time | 37 Days | 17 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
SUPRA is currently trading at Rp3.006 with a market cap of Rp98.21 million, exhibiting a strong bearish technical signal across moving averages and oscillators. The token's circulation rate is 33%, with an average hold time of 17 days. Current technical indicators show RSI levels in the oversold territory, suggesting potential for a short-term bounce, while ADX readings indicate a strong downtrend. No major protocol updates or ecosystem developments were identified in recent research.
The overall outlook remains cautious due to prevailing bearish momentum and limited fundamental catalysts. Key opportunities include potential oversold rebounds, while major risks involve low liquidity, high volatility, and the token's relatively small market capitalization making it susceptible to price swings. Investors should monitor for any significant ecosystem developments or changes in market sentiment.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About SUPRA
Supra is the first blockchain built for Automatic DeFi (AutoFi), an automated financial system. As a Layer-1 solution, it supports high-speed smart contracts with integrated data and AI oracles, automation, and cross-chain messaging. This allows for innovative AutoFi features that generate revenue and redistribute it to applications and node operators, reducing reliance on block rewards over time. The Supra stack also provides AI agents with the tools needed to create and execute effective AutoFi strategies for users in a fully on-chain, secure, and autonomous manner.
Read more on SUPRA →
